UMINESCE: Phase 3 study of satralizumab, a therapeutic recycling antibody targeting the IL-6 receptor, in patients with generalised myasthenia gravis

被引：0
|
作者：
Kaminski, H. [1 ]
Zhao, C. [2 ]
zu Horste, G. Meyer [3 ]
O'Connor, K. [4 ]
Klingelschmitt, G. [5 ]
Krumova, P. [5 ]
Bolt, S. [6 ]
Vodopivec, I. [5 ]
Murai, H. [7 ]
机构：
[1] George Washington Univ, Washington, DC USA
[2] Fudan Univ, Shanghai, Peoples R China
[3] Univ Munster, Munster, Germany
[4] Yale Univ, New Haven, CT USA
[5] F Hoffmann La Roche Ltd, Basel, Switzerland
[6] Roche Prod, Welwyn Garden City, Herts, England
[7] Univ Hlth & Welf, Narita, Japan
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.162
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.92
引用
收藏
页码：S80 / S81
页数：2
相关论文
共 50 条
  • [41] Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway
    Yiyi Ji
    Bo Liu
    Lei Chen
    Ang Li
    Kai Shen
    Ruopeng Su
    Weiwei Zhang
    Yinjie Zhu
    Qi Wang
    Wei Xue
    Cellular Oncology, 2023, 46 : 1445 - 1456
  • [42] Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Murai, Hiroyuki
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    NEUROLOGY, 2021, 96 (15)
  • [43] Rational Effectiveness of an Anti-Mouse IL-6 Receptor Monoclonal Antibody in Chemotherapy Targeting Colon Cancer Stem Cells
    Jin, Ying
    Tsujii, Masahiko
    Kondo, Jumpei
    Hayashi, Yoshito
    Kato, Motohiko
    Akasaka, Tomofumi
    Inoue, Takuya
    Shiraishi, Eri
    Inoue, Takahiro
    Hiyama, Satoshi
    Tsujii, Yoshiki
    Maekawa, Akira
    Kawai, Shoichiro
    Fujinaga, Tetsuji
    Araki, Mamoru
    Shinzaki, Shinichiro
    Watabe, Kenji
    Nishida, Tsutomu
    Iijima, Hideki
    Takehara, Tetsuo
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (09) : 2017 - 2017
  • [44] A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD
    Nowak, Kristen L.
    Kakkar, Rahul
    Devalaraja, Matt
    Lo, Larry
    Park, Wansu
    Gobburu, Joga
    Kling, Douglas
    Davidson, Michael
    Chonchol, Michel
    KIDNEY360, 2021, 2 (02): : 224 - 235
  • [45] Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study
    Pasnoor, Mamatha
    Bril, Vera
    Levine, Todd
    Trivedi, Jaya
    Silvestri, Nicholas J.
    Phadnis, Milind
    Katzberg, Hans D.
    Saperstein, David S.
    Wolfe, Gil I.
    Herbelin, Laura
    Higgs, Kiley
    Heim, Andrew J.
    Statland, Jeffrey M.
    Barohn, Richard J.
    Dimachkie, Mazen M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (05) : 1417 - 1424
  • [46] Tocilizumab, a novel monoclonal antibody targeting IL-6 signalling, significantly reduces disease activity in patients with rheumatoid arthritis
    Smolen, J.
    Beaulieu, A.
    Rubbert-Roth, A.
    Alecock, E.
    Alten, R.
    Woodworth, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 87 - 88
  • [47] Tocilizumab, a novel monoclonal antibody targeting il-6 signalling, significantly improves quality of life in patients with rheumatoid arthritis
    Allen, R.
    Ramos-Remus, C.
    Rovensky, J.
    Lucero, M.
    Woodworth, T.
    Smolens, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 428 - 428
  • [48] Important molecular differences between therapeutic IL-6 receptor inhibition and its genetic mimicry in patients with AD
    Garhers, Christoph
    Werfel, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (06) : 1559 - 1559
  • [49] SATISFY-JP, a phase II multicenter open-label study on Satralizumab, an anti-IL-6 receptor antibody, use for the treatment of pulmonary arterial hypertension in patients with an immune-responsive-phenotype: Study protocol
    Tamura, Yuichi
    Takeyasu, Rika
    Takata, Tomohiro
    Miyazaki, Naoki
    Takemura, Ryo
    Wada, Michihiko
    Tamura, Yudai
    Abe, Kohtaro
    Shigeta, Ayako
    Taniguchi, Yu
    Adachi, Shiro
    Inami, Takumi
    Tsujino, Ichizo
    Tahara, Nobuhiro
    Kuwana, Masataka
    PULMONARY CIRCULATION, 2023, 13 (02)
  • [50] Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebocontrolled, multicentre study (vol 16, pg 976, 2017)
    Howard, J. F., Jr.
    Utsugisawa, K.
    Benatar, M.
    LANCET NEUROLOGY, 2017, 16 (12): : 954 - 954
12345